bpc-157 multiple sclerosis study Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System 2024 Multiple Sclerosis Highlight -

it has been used topically for decades without serious adverse events, and injectable formulations in animal models show no organ toxicity at doses up to 50 mg/kg" [8]

The coding must reflect the diabetes indication as primary

Here's a few reasons: Third-Party Lab Testing: Xcel Peptides gets every BPC-157 batch tested by an independent lab and posts the lab reports online

Molecular Weight: 299.49 g/mol

And the modulatory rather than stimulatory nature of its effects on systems like nitric oxide and inflammation suggests a lower risk of overcorrection compared to directionally-acting compounds

Antioxidant Properties Research in rats has shown that BPC-157 can neutralize certain oxidative stress markers like nitric oxide and malondialadehyde (MDA) [3]